Kayne Anderson Rudnick Investment Management
TEVA icon

Kayne Anderson Rudnick Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History

Kayne Anderson Rudnick Investment Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-20,678
Closed -$664K – 341
2017
Q1 		$664K Buy
20,678
+5,475
+36% +$187K 0.01% 309
2016
Q4 		$551K Sell
15,203
-5,088
-25% -$203K 0.01% 304
2016
Q3 		$934K Sell
20,291
-43,317
-68% -$2.26M 0.01% 290
2016
Q2 		$3.19M Sell
63,608
-796
-1% -$42.4K 0.05% 201
2016
Q1 		$3.45M Buy
64,404
+6,952
+12% +$408K 0.06% 180
2015
Q4 		$3.77M Buy
57,452
+25,380
+79% +$1.57M 0.06% 172
2015
Q3 		$1.81M Sell
32,072
-5,918
-16% -$384K 0.03% 215
2015
Q2 		$2.25M Buy
37,990
+1,665
+5% +$103K 0.03% 209
2015
Q1 		$2.26M Buy
36,325
+1,479
+4% +$86K 0.04% 202
2014
Q4 		$2M Buy
34,846
+1,376
+4% +$76.7K 0.03% 209
2014
Q3 		$1.8M Buy
33,470
+3,827
+13% +$203K 0.03% 210
2014
Q2 		$1.55M Buy
29,643
+1,779
+6% +$90.9K 0.03% 218
2014
Q1 		$1.47M Buy
27,864
+2,082
+8% +$96.2K 0.03% 217
2013
Q4 		$1.03M Buy
25,782
+2,059
+9% +$81.1K 0.02% 230
2013
Q3 		$896K Buy
23,723
+1,068
+5% +$41.7K 0.02% 227
2013
Q2 		$888K Buy
+22,655
New +$882K 0.02% 217

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's TEVA Position: Q2 2017 in Review

Kayne Anderson Rudnick Investment Management sold out of Teva Pharmaceuticals (TEVA) in Q2 2017, closing a stake of 20,678 shares — an estimated $664K sold.

Kayne Anderson Rudnick Investment Management first reported a position in TEVA in Q2 2013 and held it in 16 quarters. The position peaked at $3.77M in Q4 2015. 649 funds tracked by Wall St. Rank hold TEVA as of Q2 2017.

  • Kayne Anderson Rudnick Investment Management reported no remaining Teva Pharmaceuticals position as of Q2 2017 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 20,678 Teva Pharmaceuticals shares in Q2 2017, an estimated $664K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 16 quarters.
  • Kayne Anderson Rudnick Investment Management's Teva Pharmaceuticals position peaked at $3.77M in Q4 2015.
  • 649 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2017.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2017, filed 9 Aug 2017.